Search All News
In children with certain autism mutations, the diversity and severity of symptoms are often related to the identity and properties of gene units, called exons, targeted by the mutations.
Columbia researchers have found a potential neurobiological mechanism for hallucinations and delusions that fits within the hierarchical model of psychosis and can explain their clinical presentation.
A third of youths in New York City foster care identify as LGBTQAI+, finds a study by Columbia researcher Theo Sandfort. But why so many gender diverse youths end up in foster care is unclear.
- March 31, 2016
Long-acting naltrexone reduced the risk of relapse among people being treated for opioid dependence, a new study reports.
- March 16, 2016
Researchers from Columbia and the National Institute on Alcohol Abuse and Alcoholism have found that the number of Americans with marijuana use disorder has nearly doubled, but few get treatment.
- March 11, 2016
Researchers have found that treatment with very low doses of a dopamine-1 receptor (D1R) agonist was not effective in reducing the cognitive and negative symptoms of schizophrenia.
- February 25, 2016
Scientists have developed a new optical technique to study how information is transmitted in the brains of mice. Using this method, they found that only a small portion of synapses—the connections between cells that control brain activity—may be active at any given time.
- February 18, 2016
In studies in mice, Zuckerman Institute researchers have discovered a way to restore memory deficits found in schizophrenia by regrowing lost neuronal connections.
- January 6, 2016
A Mailman School of Public Health study suggests gender differences in depression and anxiety may have more socially constructed roots than previously thought.
- December 23, 2015
The Department of Psychiatry's Reiner Center, located on the fifteenth floor of Presbyterian Hospital, opened with a ribbon-cutting ceremony this week.
- December 21, 2015
Increased connectivity in the brain's default mode network is a potential precursor, or biomarker, indicating a risk of developing major depressive disorder.